IBD or strongyloidiasis?

Autor: Puglia Santos, Mora Miguel F, Artero-Fullana A, Andrade Gamarra, Marco Marqués A, Burgués Gasión O, Boscá Watts Mm, Lanza Reynolds B, Savall-Núñez E

Publikováno v: Revista Espanola de Enfermedades Digestivas, Vol 108, Iss 8, Pp 516-520

Introduction: Strongyloides has been shown to infrequently mimic inflammatory bowel disease (IBD) or to disseminate when a patient with IBD and unrecognized strongyloides is treated with immunosupression. Case report: A man from Ecuador, living in Sp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a8a5d64b3822e039e505ac868cc91b5
https://pubmed.ncbi.nlm.nih.gov/26634698

Queratoacantoma digital distal: importancia del diagnóstico diferencial con el carcinoma escamoso subungueal

Autor: González-Rodríguez, A.J., Gutiérrez-Paredes, E.M., Montesinos-Villaescusa, E., Burgués Gasión, O., Jordá-Cuevas, E.

Publikováno v: In Actas dermosifiliograficas July-August 2012 103(6):549-551

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.

Autor: Cejalvo JM; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain., Martínez de Dueñas E; Hospital Provincial de Castellón, Castellón, Spain.; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Galván P; Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., García-Recio S; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Burgués Gasión O; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Department of Pathology, Hospital Clínico Universitario de Valencia, Spain., Paré L; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Antolín S; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Complejo Hospitalario Universitario A Coruña, A Coruña, Spain., Martinello R; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Blancas I; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Clínico San Cecilio, Complejo Hospitalario de Granada, Granada, Spain., Adamo B; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Guerrero-Zotano Á; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Instituto Valenciano de Oncología, Valencia, Spain., Muñoz M; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Nucíforo P; Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Vidal M; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Pérez RM; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Universitario Quirón de Madrid, Madrid, Spain., Chacón López-Muniz JI; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital Virgen de la Salud, Toledo, Spain., Caballero R; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Peg V; Pathology Department, Hospital Vall d'Hebron, Barcelona, Spain., Carrasco E; GEICAM, Spanish Breast Cancer Group, Madrid, Spain., Rojo F; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Fundación Jiménez Díaz, Madrid, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain., Perou CM; University of North Carolina, Chapel Hill, North Carolina., Cortés J; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Ramón y Cajal University Hospital, Madrid, Spain., Adamo V; University of Messina, Messina, Italy., Albanell J; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Hospital del Mar, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain., Gomis RR; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain.; ICREA, Barcelona, Spain., Lluch A; GEICAM, Spanish Breast Cancer Group, Madrid, Spain.; Department of Hematology and Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.; Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain., Prat A; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. alprat@clinic.cat.; Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.

Publikováno v: Cancer research [Cancer Res] 2017 May 01; Vol. 77 (9), pp. 2213-2221. Date of Electronic Publication: 2017 Mar 01.